203 related articles for article (PubMed ID: 33784991)
1. Effectiveness of early switching from intravenous to oral antibiotic therapy in Staphylococcus aureus prosthetic bone and joint or orthopedic metalware-associated infections.
Boclé H; Lavigne JP; Cellier N; Crouzet J; Kouyoumdjian P; Sotto A; Loubet P
BMC Musculoskelet Disord; 2021 Mar; 22(1):315. PubMed ID: 33784991
[TBL] [Abstract][Full Text] [Related]
2. Early switching from intravenous to oral antibiotic therapy in bone and joint infections associated with methicillin-susceptible Staphylococcus aureus bacteremia.
Petithomme-Nanrocki M; Vernet-Garnier V; Lebrun D; Bajolet O; Bonnet M; Hentzien M; Ohl X; Diallo S; Bani-Sadr F
Infect Dis Now; 2023 Sep; 53(6):104739. PubMed ID: 37331697
[TBL] [Abstract][Full Text] [Related]
3. Suppressive antibiotic therapy with oral doxycycline for Staphylococcus aureus prosthetic joint infection: a retrospective study of 39 patients.
Pradier M; Nguyen S; Robineau O; Titecat M; Blondiaux N; Valette M; Loïez C; Beltrand E; Dézeque H; Migaud H; Senneville E
Int J Antimicrob Agents; 2017 Sep; 50(3):447-452. PubMed ID: 28668689
[TBL] [Abstract][Full Text] [Related]
4. Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration.
Peeters O; Ferry T; Ader F; Boibieux A; Braun E; Bouaziz A; Karsenty J; Forestier E; Laurent F; Lustig S; Chidiac C; Valour F;
BMC Infect Dis; 2016 Nov; 16(1):622. PubMed ID: 27809799
[TBL] [Abstract][Full Text] [Related]
5. A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention.
Lora-Tamayo J; Murillo O; Iribarren JA; Soriano A; Sánchez-Somolinos M; Baraia-Etxaburu JM; Rico A; Palomino J; Rodríguez-Pardo D; Horcajada JP; Benito N; Bahamonde A; Granados A; del Toro MD; Cobo J; Riera M; Ramos A; Jover-Sáenz A; Ariza J;
Clin Infect Dis; 2013 Jan; 56(2):182-94. PubMed ID: 22942204
[TBL] [Abstract][Full Text] [Related]
6. Implant retention and high rate of treatment failure in hematogenous acute knee and hip prosthetic joint infections.
Pansu N; Hamoui M; Manna F; Makinson A; Dufour S; Morquin D; Canovas F; Reynes J; Le Moing V
Med Mal Infect; 2020 Nov; 50(8):702-708. PubMed ID: 31848104
[TBL] [Abstract][Full Text] [Related]
7. Higher risk of failure of methicillin-resistant Staphylococcus aureus prosthetic joint infections.
Salgado CD; Dash S; Cantey JR; Marculescu CE
Clin Orthop Relat Res; 2007 Aug; 461():48-53. PubMed ID: 17534195
[TBL] [Abstract][Full Text] [Related]
8. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
[TBL] [Abstract][Full Text] [Related]
9. Should we expand the indications for the DAIR (debridement, antibiotic therapy, and implant retention) procedure for Staphylococcus aureus prosthetic joint infections? A multicenter retrospective study.
Lesens O; Ferry T; Forestier E; Botelho-Nevers E; Pavese P; Piet E; Pereira B; Montbarbon E; Boyer B; Lustig S; Descamps S;
Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1949-1956. PubMed ID: 30083889
[TBL] [Abstract][Full Text] [Related]
10. Staphylococcus aureus versus Staphylococcus epidermidis in periprosthetic joint infection-Outcome analysis of methicillin-resistant versus methicillin-susceptible strains.
Hischebeth GT; Randau TM; Ploeger MM; Friedrich MJ; Kaup E; Jacobs C; Molitor E; Hoerauf A; Gravius S; Wimmer MD
Diagn Microbiol Infect Dis; 2019 Feb; 93(2):125-130. PubMed ID: 30266398
[TBL] [Abstract][Full Text] [Related]
11. Outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus.
Senneville E; Joulie D; Legout L; Valette M; Dezèque H; Beltrand E; Roselé B; d'Escrivan T; Loïez C; Caillaux M; Yazdanpanah Y; Maynou C; Migaud H
Clin Infect Dis; 2011 Aug; 53(4):334-40. PubMed ID: 21810745
[TBL] [Abstract][Full Text] [Related]
12. Prosthetic joint infections due to Staphylococcus aureus and coagulase-negative staphylococci.
Tornero E; García-Oltra E; García-Ramiro S; Martínez-Pastor JC; Bosch J; Climent C; Morata L; Camacho P; Mensa J; Soriano A
Int J Artif Organs; 2012 Oct; 35(10):884-92. PubMed ID: 23138701
[TBL] [Abstract][Full Text] [Related]
13. Non-compliance with IDSA guidelines for patients presenting with methicillin-susceptible Staphylococcus aureus prosthetic joint infection is a risk factor for treatment failure.
Bouaziz A; Uçkay I; Lustig S; Boibieux A; Lew D; Hoffmeyer P; Neyret P; Chidiac C; Ferry T
Med Mal Infect; 2018 May; 48(3):207-211. PubMed ID: 29122410
[TBL] [Abstract][Full Text] [Related]
14. Factors predictive of treatment failure in staphylococcal prosthetic vascular graft infections: a prospective observational cohort study: impact of rifampin.
Legout L; Delia P; Sarraz-Bournet B; Rouyer C; Massongo M; Valette M; Leroy O; Haulon S; Senneville E
BMC Infect Dis; 2014 Apr; 14():228. PubMed ID: 24775563
[TBL] [Abstract][Full Text] [Related]
15. Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCT.
Thwaites GE; Scarborough M; Szubert A; Saramago Goncalves P; Soares M; Bostock J; Nsutebu E; Tilley R; Cunningham R; Greig J; Wyllie SA; Wilson P; Auckland C; Cairns J; Ward D; Lal P; Guleri A; Jenkins N; Sutton J; Wiselka M; Armando GR; Graham C; Chadwick PR; Barlow G; Gordon NC; Young B; Meisner S; McWhinney P; Price DA; Harvey D; Nayar D; Jeyaratnam D; Planche T; Minton J; Hudson F; Hopkins S; Williams J; Török ME; Llewelyn MJ; Edgeworth JD; Walker AS
Health Technol Assess; 2018 Oct; 22(59):1-148. PubMed ID: 30382016
[TBL] [Abstract][Full Text] [Related]
16. Moxifloxacin plus rifampin as an alternative for levofloxacin plus rifampin in the treatment of a prosthetic joint infection with Staphylococcus aureus.
Wouthuyzen-Bakker M; Tornero E; Morata L; Nannan Panday PV; Jutte PC; Bori G; Kampinga GA; Soriano A
Int J Antimicrob Agents; 2018 Jan; 51(1):38-42. PubMed ID: 28668678
[TBL] [Abstract][Full Text] [Related]
17. Oral Therapy, Microbiological Findings, and Comorbidity Influence the Outcome of Prosthetic Joint Infections Undergoing 2-Stage Exchange.
Ascione T; Pagliano P; Balato G; Mariconda M; Rotondo R; Esposito S
J Arthroplasty; 2017 Jul; 32(7):2239-2243. PubMed ID: 28372916
[TBL] [Abstract][Full Text] [Related]
18. Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT.
Scarborough M; Li HK; Rombach I; Zambellas R; Walker AS; McNally M; Atkins B; Kümin M; Lipsky BA; Hughes H; Bose D; Warren S; Mack D; Folb J; Moore E; Jenkins N; Hopkins S; Seaton RA; Hemsley C; Sandoe J; Aggarwal I; Ellis S; Sutherland R; Geue C; McMeekin N; Scarborough C; Paul J; Cooke G; Bostock J; Khatamzas E; Wong N; Brent A; Lomas J; Matthews P; Wangrangsimakul T; Gundle R; Rogers M; Taylor A; Thwaites GE; Bejon P
Health Technol Assess; 2019 Aug; 23(38):1-92. PubMed ID: 31373271
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Outcomes of Staphylococcus aureus Implant-associated Infections in Children.
Foster CE; Lamberth LB; Kaplan SL; Hulten KG
Pediatr Infect Dis J; 2019 Aug; 38(8):808-811. PubMed ID: 31033905
[TBL] [Abstract][Full Text] [Related]
20. Ceftaroline fosamil for treatment of diabetic foot infections: the CAPTURE study experience.
Lipsky BA; Cannon CM; Ramani A; Jandourek A; Calmaggi A; Friedland HD; Goldstein EJ
Diabetes Metab Res Rev; 2015 May; 31(4):395-401. PubMed ID: 25417910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
